- RecruitingPHASE3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
This study is looking into a new medication called AZD0780. It aims to see if this medicine can lower the risk of serious heart problems like heart attacks or strokes in people who have already had them, or in those at high risk of having one for the first time.
For: Cardiovascular DiseaseUnited States · Argentina · Brazil - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIb, Multicenter, Randomized, Parallel-group, Double- blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants with Dyslipidemia
This study looks at a new medicine called AZD0780 for people with high cholesterol. We want to see if it safely lowers bad cholesterol and other fats in the blood, which can help prevent heart problems. Participants will take the medicine or a dummy pill.
For: which is a major risk factor for Cardiovascular Disease (CVD) · such as Ischemic Heart Disease and Ischemic Stroke. CVD is a leading cause of global mortality and a contributor to disability.Denmark · Czechia · Spain - Active not recruitingPHASE3
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
This study looks at a new drug, AZD0780, for people with heart disease or who are at risk of it, and who have high 'bad' cholesterol (LDL-C). We want to see if AZD0780 safely lowers this cholesterol.
For: Cardiovascular DiseaseUnited States · Argentina · Australia